Work

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-015-0246-2

Authors: Katrina S. Pedersen, George P. Kim, Nathan R. Foster, Andrea Wang-Gillam, Charles Erlichman, Robert R. McWilliams

Institutions: Mayo Clinic, Washington University in St. Louis

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1655353241, G1828094709, Mayo Clinic SPORE in Pancreatic Cancer, G4512719699, Mayo Clinic SPORE in Pancreatic Cancer, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W275026060

FWCI: 2.008

Cites: 28

Cited by: 52

Related to: 10